The Enterprise Value as of April 2026 (TTM) for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is 356.05M

According to Drugs Made In America Acquisition Corp. Ordinary Shares’s latest financial reports and current stock price. The company's current Enterprise Value is 356.05M. This represents a change of 59.61% compared to the average of 223.08M of the last 4 quarters.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Historical Enterprise Value (quarterly & annually)

How has DMAA Enterprise Value performed in the past?

The mean historical Enterprise Value of Drugs Made In America Acquisition Corp. Ordinary Shares over the last ten years is 151.61M. The current 356.05M Enterprise Value has changed 23.38% with respect to the historical average. Over the past ten years (40 quarters), DMAA's Enterprise Value was at its highest in in the June 2025 quarter at 341.87M. The Enterprise Value was at its lowest in in the June 2024 quarter at 54.71M.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Drugs Made In America Acquisition Corp. Ordinary Shares Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Average Enterprise Value

How has DMAA Enterprise Value performed in the past?

The current Enterprise Value of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Enterprise Value vs. Peers

How is DMAA’s Enterprise Value compared to its peers?

Drugs Made In America Acquisition Corp. Ordinary Shares’s Enterprise Value is greater than SIM Acquisition Corp. I (329.60M), greater than Mountain Lake Acquisition Corp. (327.14M), less than Berto Acquisition Corp. Unit (411.38M), less than Centurion Acquisition Corp. (388.38M), less than Berto Acquisition Corp. (388.06M), greater than Live Oak Acquisition Corp. V Class A Ordinary Shares (299.11M), greater than Titan Acquisition Corp. (354.97M), greater than Oyster Enterprises II Acquisition Corp (346.15M), greater than Renatus Tactical Acquisition Corp I Class A Ordinary Shares (322.45M),

Build a custom stock screener for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Drugs Made In America Acquisition Corp. Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Drugs Made In America Acquisition Corp. Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.